Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.
about
Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodelingCold hands--strained heart? Advances in the management of Raynaud's phenomenon and pulmonary hypertensionSphingosine kinase 1/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertensionEffect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in ratsEndothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal ratNeuronal nitric oxide inhibits intestinal smooth muscle growthPositive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertensionMice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension.Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification.Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1/2 signalling.Reversal of experimental pulmonary hypertension by PDGF inhibition.Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: role of the cytoskeletal protein cofilin in pulmonary hypertension.Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchangeFunctions of serotonin in hypoxic pulmonary vascular remodeling.S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats.Human immunodeficiency virus transgenic rats exhibit pulmonary hypertensionEffects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1Thromboxane promotes smooth muscle phenotype commitment but not remodeling of hypoxic neonatal pulmonary arteryDehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.Role of veins in regulation of pulmonary circulation.Polydatin attenuates hypoxic pulmonary hypertension and reverses remodeling through protein kinase C mechanismsPulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone systemTASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries.Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiologyEffect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension.Determination of PKC isoform-specific protein expression in pulmonary arteries of rats with chronic hypoxia-induced pulmonary hypertension.Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with.Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways.Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growthRole of arginase in vessel wall remodeling.Possible role of nitric oxide in the pathogenesis of pulmonary hypertension in broilers: a synopsis.Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.Deciphering the genetic and modular connections between coronary heart disease, idiopathic pulmonary arterial hypertension and pulmonary heart disease.Hypoxia promotes cell proliferation by modulating E2F1 in chicken pulmonary arterial smooth muscle cells.Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia.
P2860
Q24647096-138CDA6C-7B3B-40F4-B036-4DF6419DBA66Q24816970-2F42659F-85DB-4679-86BA-9A800666EC64Q26778497-6C67D570-B5B9-4443-839C-3B5F3BE152F6Q28569530-8AAAABB0-E63F-4B93-926D-9A57351912FDQ28569830-EA6FB583-0AB6-4C31-85B2-3A877FAD45FBQ28570540-736B6A8E-E109-497D-896A-B5225DA44AEDQ28581184-1B873A73-FD4F-4242-8111-4E2427217375Q33256255-E6C14825-DCBD-4DB6-B7F6-D43C67783C60Q33293918-177205B2-328E-4215-9ED7-0B84A1AB98C7Q33393513-32360915-FEF3-41AE-B8C7-2EEFFACA1B00Q33929749-B8DBA45C-5A6E-43F0-96E5-1C15DEC9C1CCQ34048479-D93539EA-6AF4-4761-9014-329D80833E85Q34480694-6CDEFB5D-1B1D-4E85-923C-89DA88A1CB6CQ34586634-645EA8E2-0586-45D0-966E-8268A1B313E6Q34653768-63D3B34E-A5DB-4B55-8141-C2C9948A5BC5Q35045079-FA771FC1-96B5-46B2-9CE2-B4C19269BCB8Q35217383-C0C93690-F518-47EB-B7BB-AD57A46937A6Q35622046-C31011C5-A151-4FF3-A430-A2D19CA77F40Q35684903-70A93CEA-32B8-49E7-B59B-6821E8E4FEABQ35846004-32EDD2C7-8BC8-429B-82DF-19632BD5A7BCQ35946199-BC20E169-1905-4654-A250-C1EFEFC48981Q36004121-2E0728FC-578F-49A2-80F7-7CA0A26FF095Q36097046-DD9A1705-A9A3-428D-AA1B-84C1B169FC4DQ36159683-18D0902B-10E2-4C84-BEE1-9A67761992B9Q36310811-6BF2832A-1CD7-4A57-BF40-3886D662AD9EQ36314822-AA2275D0-12A5-4E17-AAA4-E54A7E7D490DQ36353546-66B4D3EE-11A9-4DCA-BCC7-C9B1E66CF1CAQ36472968-9434D9C7-B88B-44F7-BF6A-162C31981645Q36527952-F42C0CEC-7D7D-48D2-A4EF-2EAF84CA1AE3Q36576910-DF81DA69-B4A7-41C5-9C53-6C8FFD43B1D1Q36584877-DDD8FBA7-C49E-4B0D-8048-675CA6E42D62Q36595077-3FB04826-25BF-4CC6-9592-A3B43A41DB83Q36681338-9552D3F3-94F6-4DCB-A78F-FB1583D9C618Q36735344-F5B77194-23C0-4DA1-8030-844C7BF7BE58Q36837617-D2B47005-19D2-4DAA-91BB-EFAAABD20575Q36874431-4CCF8D37-DA9F-42A5-B63E-EECDE1C2DA56Q37018303-78B0EC0A-68B6-4FE1-9E6B-F23694C3CC49Q37032419-2EDFD905-4EDF-47BE-A17D-06A184E221F1Q37152760-F1190E21-A292-4CD7-AE62-AE5F7D3104D8Q37281642-C475C1D4-C718-469E-A54A-A5664DF85ECA
P2860
Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@ast
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@en
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@nl
type
label
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@ast
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@en
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@nl
prefLabel
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@ast
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@en
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@nl
P1476
Pulmonary vascular remodeling: ...... ion in pulmonary hypertension.
@en
P2093
Jeffery TK
Wanstall JC
P356
10.1016/S0163-7258(01)00157-7
P577
2001-10-01T00:00:00Z